EUVIMED · CrossrefZeitschrift
European Journal of Oncology Pharmacy
ISSN 2032-7072 · Ovid Technologies (Wolters Kluwer Health)
Neueste Artikel
LETTER OF WELCOME
CONFERENCE COMMITTEES
ACCREDITATION INFORMATION
GENERAL INFORMATION
ESOP PROFILE
PROGRAMME OVERVIEW
SCIENTIFIC PROGRAMME
AUTHOR INDEX
ACKNOWLEDGEMENTS
VENUE FLOOR PLAN
EXHIBITORS AND EXHIBITOR PROFILES
Comparative evaluation of a website for drug incompatibility
Experience with instrumental methods in radiopharmacy as a tool of radiation protection optimization
Implementation of pharmacist consultations as part of a multidisciplinary consultation program for patients with oral anticancer agent
ABSTRACTS
Assessment of medication use process in adult oncology unit of Tikur Anbesa Specialized Hospital
Treatment options for patients with mantle cell lymphoma post-transplantation
Antiangiogenesis activity test of tin leaf (Ficus carica L.) on the number of blood vessels and VEGF expression of chorioallantoic membrane of embryonated chicken eggs
Proceedings Book for 4th ECOP (European Conference of Oncology Pharmacy) 25–27 October 2018, Nantes, France: Erratum
Synadenium umbellatum and the Ehrlich's solid tumor treatment
Impact of outpatient pharmacy services collaborating with oncologists at an outpatient clinic for outpatient chemotherapy prescription orders
Pharmaceutical consultations in oncology: French Society for Oncology Pharmacy (Société Francaise de Pharmacie Oncologique – SFPO) guidelines
Stability studies in oncology
Assessment of breast cancer treatment outcome at Tikur Anbessa Specialized Hospital Adult Oncology Unit, Addis Ababa, Ethiopia
Chemotherapy supply chain safety: current data from public oncology centers in Morocco
Patient satisfaction with information on chemotherapy
Quality control of cytotoxic infusions disturbed by a change of infusion bag
Simulation to assess intelligent video camera system's actual production performance during chemotherapy preparation
Afatinib, an irreversible ErbB family blocker for the treatment of epidermal growth factor receptor mutation-positive non-small cell lung cancer
Improving the safety of chemotherapy process by a risks management tool
EUVIMED